Search research articles
Contact Us
Filters
Showing results (231-240 of 310) with videos related to
Page
of 31
Sort By:
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
February 10, 2019
Elevated Serum Markers of Acute Kidney Injury in Patients With Obstructive Sleep Apnea
Li-Pang Chuang, Shih-Wei Lin, Li-Ang Lee, et al.
BMC Infectious Diseases
|
February 21, 2012
Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit
Chen-Yiu Hung, Kuo-Chin Kao, Po-Nan Wang, et al.
Oncology Reports
|
October 28, 2015
Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells
Ming-Szu Hung, I-Chuan Chen, Liang You, et al.
Cancer Research and Treatment
|
March 28, 2022
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
Byoung Chul Cho, Dong-Wan Kim, Ullas Batra, et al.
American Journal of Cancer Research
|
September 11, 2023
Clinical outcome analysis of non-small cell lung cancer patients with brain metastasis receiving metastatic brain tumor resection surgery: a multicenter observational study
Ping-Chih Hsu, Li-Chung Chiu, Ko-Ting Chen, et al.
Cancers
|
July 27, 2022
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab
How-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang, et al.
Medicine
|
May 19, 2025
Impact of ejection fraction changes on long-term outcomes in VA-ECMO patients
Cheng-Ta Yang, Yu-Ting Cheng, Yi-Hsin Chan, et al.
Chemotherapy
|
April 15, 2015
Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma
Scott Chih-Hsi Kuo, Ping-Chih Hsu, Chih-Hung Chen, et al.
Therapeutic Advances in Medical Oncology
|
June 29, 2026
Clinical characteristics and outcomes of advanced EGFR-mutated NSCLC treated with 45 or 30 mg starting doses of dacomitinib: a retrospective multicenter analysis
Ping-Chih Hsu, How-Wen Ko, Li-Chung Chiu, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 29, 2020
The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study
Ping-Chih Hsu, Chun-Yao Huang, Chin-Chou Wang, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 310) with videos related to
Sort By:
Page
of 31
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
February 10, 2019
Elevated Serum Markers of Acute Kidney Injury in Patients With Obstructive Sleep Apnea
Li-Pang Chuang, Shih-Wei Lin, Li-Ang Lee, et al.
BMC Infectious Diseases
|
February 21, 2012
Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit
Chen-Yiu Hung, Kuo-Chin Kao, Po-Nan Wang, et al.
Oncology Reports
|
October 28, 2015
Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells
Ming-Szu Hung, I-Chuan Chen, Liang You, et al.
Cancer Research and Treatment
|
March 28, 2022
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
Byoung Chul Cho, Dong-Wan Kim, Ullas Batra, et al.
American Journal of Cancer Research
|
September 11, 2023
Clinical outcome analysis of non-small cell lung cancer patients with brain metastasis receiving metastatic brain tumor resection surgery: a multicenter observational study
Ping-Chih Hsu, Li-Chung Chiu, Ko-Ting Chen, et al.
Cancers
|
July 27, 2022
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab
How-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang, et al.
Medicine
|
May 19, 2025
Impact of ejection fraction changes on long-term outcomes in VA-ECMO patients
Cheng-Ta Yang, Yu-Ting Cheng, Yi-Hsin Chan, et al.
Chemotherapy
|
April 15, 2015
Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma
Scott Chih-Hsi Kuo, Ping-Chih Hsu, Chih-Hung Chen, et al.
Therapeutic Advances in Medical Oncology
|
June 29, 2026
Clinical characteristics and outcomes of advanced EGFR-mutated NSCLC treated with 45 or 30 mg starting doses of dacomitinib: a retrospective multicenter analysis
Ping-Chih Hsu, How-Wen Ko, Li-Chung Chiu, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 29, 2020
The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study
Ping-Chih Hsu, Chun-Yao Huang, Chin-Chou Wang, et al.
Page
of 31